CA
NZ
UK
AU
IND
US
Core income, a non-GAAP measure, was $20.4 million, down 33.1% from $30.5 million, or $0.42 per diluted share compared with $0.61. For the nine months, net income was $60.5 million, or $1.23 per diluted share, versus $80.3 million, or $1.61.
Closures led with reported growth of 11%, helped by strongDemandfor bottled water and concentrates, a recent beverage dispensing closure and condiment sales. Beauty reported 9% growth on demand for prestige fragrance, color cosmetics and hair care, and pass throughs of higher input costs added …
Reported net earnings were $406 million, compared with $273 million, and reported diluted EPS rose to $1.55 from $1.04. Adjusted net earnings were $782 million versus $604 million, and adjusted EPS was $3.00 versus $2.31.
Total revenue was $40.0 million, up $3.8 million, or 10%, from $36.3 million. Recurring revenue of $36.9 million increased $5.1 million, or 16%, which the company attributed mainly to payroll solutions. Recurring revenue represented over 92% of the total, compared with 88% a year …
Adjusted EBITDA, a non-GAAP measure that removes interest, depreciation, amortization and stock-based compensation, was a loss of $4.6 million versus a loss of $4.4 million.
In its quarterly filing for the three months ended September 30, 2026, the company reportedNet Incomeof $129.6 million, or $2.25 per diluted share. That compares with $112.4 million, or $1.94 per diluted share, a year earlier, an increase of about 15% in net income …
The company reported third quarter 2026 results on October 29, 2026. Revenue reached a record $73.4 million, compared with $47.6 million in the second quarter of 2026 and $28.0 million in the third quarter of 2025.
Net loss narrowed to $129.3 million, or $0.86 per share, from $173.4 million, or $1.64, a year earlier, an improvement of about 25% on a calculated basis. Per share results also reflect a larger share count of 151.0 million weighted shares against 105.8 million.
Total revenues were $353.2 million, up $232.5 million from $120.7 million, which is about 2.9 times the prior year level on a calculated basis. Net product revenue rose $145.3 million to $253.3 million, which the company attributed to continued commercial expansion driven by patient …
Revenue increased by $38.7 million, or 5%, to $841.5 million. CEO Stephen Kramer said the quarter reflected the strength of a diversified portfolio, including 13% growth in back-up care. Growth was partly offset by lower revenue from full service centers closed over the past …
Please wait processing your request...